Literature DB >> 23697368

General mechanism for modulating immunoglobulin effector function.

Peter Sondermann1, Andrew Pincetic, Jad Maamary, Katja Lammens, Jeffrey V Ravetch.   

Abstract

Immunoglobulins recognize and clear microbial pathogens and toxins through the coupling of variable region specificity to Fc-triggered cellular activation. These proinflammatory activities are regulated, thus avoiding the pathogenic sequelae of uncontrolled inflammation by modulating the composition of the Fc-linked glycan. Upon sialylation, the affinities for Fcγ receptors are reduced, whereas those for alternative cellular receptors, such as dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)/CD23, are increased. We demonstrate that sialylation induces significant structural alterations in the Cγ2 domain and propose a model that explains the observed changes in ligand specificity and biological activity. By analogy to related complexes formed by IgE and its evolutionarily related Fc receptors, we conclude that this mechanism is general for the modulation of antibody-triggered immune responses, characterized by a shift between an "open" activating conformation and a "closed" anti-inflammatory state of antibody Fc fragments. This common mechanism has been targeted by pathogens to avoid host defense and offers targets for therapeutic intervention in allergic and autoimmune disorders.

Entities:  

Keywords:  conformational change; sialylated IgG Fc

Mesh:

Substances:

Year:  2013        PMID: 23697368      PMCID: PMC3683708          DOI: 10.1073/pnas.1307864110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Temperature effect on IgE binding to CD23 versus Fc epsilon RI.

Authors:  Bing-Hung Chen; Michelle A Kilmon; Check Ma; Timothy H Caven; Yee Chan-Li; Anne E Shelburne; Robert M Tombes; Eric Roush; Daniel H Conrad
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

3.  Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions.

Authors:  Norma J Greenfield
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Authors:  Robert M Anthony; Falk Nimmerjahn; David J Ashline; Vernon N Reinhold; James C Paulson; Jeffrey V Ravetch
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

5.  Investigation of the cooperative structure of Fc fragments from myeloma immunoglobulin G.

Authors:  V M Tischenko; V M Abramov; V P Zav'yalov
Journal:  Biochemistry       Date:  1998-04-21       Impact factor: 3.162

6.  Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.

Authors:  Bernard J Scallon; Susan H Tam; Stephen G McCarthy; Ann N Cai; T Shantha Raju
Journal:  Mol Immunol       Date:  2006-10-11       Impact factor: 4.407

7.  Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.

Authors:  M R Wormald; P M Rudd; D J Harvey; S C Chang; I G Scragg; R A Dwek
Journal:  Biochemistry       Date:  1997-02-11       Impact factor: 3.162

8.  Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.

Authors:  S Krapp; Y Mimura; R Jefferis; R Huber; P Sondermann
Journal:  J Mol Biol       Date:  2003-01-31       Impact factor: 5.469

9.  The key role of protein flexibility in modulating IgE interactions.

Authors:  Naomi E Price; Nicholas C Price; Sharon M Kelly; James M McDonnell
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

10.  The structure of human CD23 and its interactions with IgE and CD21.

Authors:  Richard G Hibbert; Peter Teriete; Gabrielle J Grundy; Rebecca L Beavil; Rajko Reljic; V Michael Holers; Jonathan P Hannan; Brian J Sutton; Hannah J Gould; James M McDonnell
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

View more
  93 in total

Review 1.  The Role and Function of Fcγ Receptors on Myeloid Cells.

Authors:  Stylianos Bournazos; Taia T Wang; Jeffrey V Ravetch
Journal:  Microbiol Spectr       Date:  2016-12

2.  Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.

Authors:  Benjamin M Fiebiger; Jad Maamary; Andrew Pincetic; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 3.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

4.  Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated Fc.

Authors:  Peter Sondermann; Andrew Pincetic; Jad Maamary; Katja Lammens; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

5.  Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy.

Authors:  Max Crispin; Xiaojie Yu; Thomas A Bowden
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-08       Impact factor: 11.205

6.  Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.

Authors:  Ian K Campbell; Sylvia Miescher; Donald R Branch; Patrick J Mott; Alan H Lazarus; Dongji Han; Eugene Maraskovsky; Adrian W Zuercher; Anton Neschadim; Danila Leontyev; Brent S McKenzie; Fabian Käsermann
Journal:  J Immunol       Date:  2014-04-23       Impact factor: 5.422

7.  Modulating IgG effector function by Fc glycan engineering.

Authors:  Tiezheng Li; David J DiLillo; Stylianos Bournazos; John P Giddens; Jeffrey V Ravetch; Lai-Xi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

Review 8.  Diversification of IgG effector functions.

Authors:  Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Int Immunol       Date:  2017-07-01       Impact factor: 4.823

Review 9.  Immunological responses to influenza vaccination: lessons for improving vaccine efficacy.

Authors:  Taia T Wang; Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Curr Opin Immunol       Date:  2018-05-10       Impact factor: 7.486

Review 10.  Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Authors:  Michaela Seeling; Christin Brückner; Falk Nimmerjahn
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.